DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development
{{output}}
Triple-negative breast cancer (TNBC) poses a significant clinical challenge due to its aggressive nature and limited therapeutic options. The interplay between DNA damage response (DDR) mechanisms and the emergence of neoantigens represents a promising avenue ... ...
